Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Pain Treatment
Sort By
Newest First
1 / 1
1 / 1
FDA Approval
FDA Permits Marketing of First Medical Device for IBS Pain Relief in Adolescent Patients
U.S. Food & Drug Administration
PR-M06-19-NI-012
Jun 13, 2019
Pain Treatment
Eli Lilly Acquires Rights to Non-Opioid Pain Treatment
Nice Insight
PAO-M05-19-NI-038
May 31, 2019
FDA Approval
FDA Approves Treatment for Patients with a Type of Inflammatory Arthritis
U.S. Food & Drug Administration
PR-M04-19-NI-001
Apr 01, 2019
Clinical Trials
Syntrix Announces First Patient Cohort Dosed in Phase 2 Study of Desmetramadol in Diabetic Neuropathic Pain
Nice Insight
PR-M03-19-NI-058
Mar 21, 2019
Phase II
Peptide Logic Awarded A $ 2.9 Million SBIR Phase II Grant To Develop Peripherally-Restricted And Long-Acting Kappa-Opioid Receptor (LA-KOR) Agonists For Moderate-To-Severe Pain
Peptide Logic
PR-M09-18-NI-056
Sep 19, 2018
